TY - JOUR
T1 - Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy
T2 - An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
AU - Lindner, Lars H.
AU - Litière, Saskia
AU - Sleijfer, Stefan
AU - Benson, Charlotte
AU - Italiano, Antoine
AU - Kasper, Bernd
AU - Messiou, Christina
AU - Gelderblom, Hans
AU - Wardelmann, Eva
AU - Le Cesne, Axel
AU - Blay, Jean Yves
AU - Marreaud, Sandrine
AU - Hindi, Nadia
AU - Desar, Ingrid M.E.
AU - Gronchi, Alessandro
AU - van der Graaf, Winette T.A.
N1 - Publisher Copyright:
© 2018 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC
PY - 2018/6/15
Y1 - 2018/6/15
N2 - The prognosis of adult soft tissue sarcoma (STS) patients with metastases is generally poor. As little is known about the impact of the involvement of different metastatic sites and the extent of pulmonary lesions on the outcome for patients receiving first-line chemotherapy, we aimed to establish prognostic factors for STS patients with lung metastases only. A retrospective, exploratory analysis was performed on 2,913 metastatic STS patients who received first-line chemotherapy. Detailed information from 580 patients who had lung metastases only, was used for prognostic factor analysis. Patients with lung metastases only were more often asymptomatic and had undergone complete primary tumor resection more frequently compared to patients with additional metastases outside the lung or without lung metastases. For extremity STS, the incidence of lung metastases only was much higher compared to non-extremity STS. Lung involvement only was an independent favorable prognostic factor for overall survival (OS) with regard to metastatic site. Within this subgroup, in a multivariate model, other factors associated with improved OS included: good performance status (PS), no progression at primary site, low histological grade, younger age, long interval between initial diagnosis and trial registration, and smaller diameter of the largest lung lesion. This unique analysis on prognostic factors in STS patients with lung metastases confirms well-known patient factors (such as age and PS), and tumor characteristics (including tumor grade, interval between primary diagnosis, and metastases), but also identifies diameter of the largest lung lesion as a new prognostic factor. Knowledge about these factors may support decision-making within multidisciplinary tumor boards.
AB - The prognosis of adult soft tissue sarcoma (STS) patients with metastases is generally poor. As little is known about the impact of the involvement of different metastatic sites and the extent of pulmonary lesions on the outcome for patients receiving first-line chemotherapy, we aimed to establish prognostic factors for STS patients with lung metastases only. A retrospective, exploratory analysis was performed on 2,913 metastatic STS patients who received first-line chemotherapy. Detailed information from 580 patients who had lung metastases only, was used for prognostic factor analysis. Patients with lung metastases only were more often asymptomatic and had undergone complete primary tumor resection more frequently compared to patients with additional metastases outside the lung or without lung metastases. For extremity STS, the incidence of lung metastases only was much higher compared to non-extremity STS. Lung involvement only was an independent favorable prognostic factor for overall survival (OS) with regard to metastatic site. Within this subgroup, in a multivariate model, other factors associated with improved OS included: good performance status (PS), no progression at primary site, low histological grade, younger age, long interval between initial diagnosis and trial registration, and smaller diameter of the largest lung lesion. This unique analysis on prognostic factors in STS patients with lung metastases confirms well-known patient factors (such as age and PS), and tumor characteristics (including tumor grade, interval between primary diagnosis, and metastases), but also identifies diameter of the largest lung lesion as a new prognostic factor. Knowledge about these factors may support decision-making within multidisciplinary tumor boards.
KW - EORTC
KW - lung metastases
KW - prognostic factors
KW - soft tissue sarcoma
UR - http://www.scopus.com/inward/record.url?scp=85042103818&partnerID=8YFLogxK
U2 - 10.1002/ijc.31286
DO - 10.1002/ijc.31286
M3 - Article
C2 - 29383713
AN - SCOPUS:85042103818
SN - 0020-7136
VL - 142
SP - 2610
EP - 2620
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 12
ER -